_openai-reverses-controversial-nda-policy-releases-former-employees-from-restrictions.jpg "OpenAI Reverses Controversial NDA Policy, Releases Former Employees from Restrictions from nbha co 03 Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 0:34
👁 View: 595K times
✓ Published: 25-May-2024
👁 View: 595K times
✓ Published: 25-May-2024
Description:
OpenAI sent an internal memo to former employees, releasing them from controversial non-disparagement agreements that they had to sign in order to keep their vested company equity. The NDAs did not have an expiration date and effectively forced employees to choose between signing them or losing their equity. The new memo stated that OpenAI would not cancel any vested equity units regardless of whether employees signed the NDAs. OpenAI co-founders expressed regret that the language around NDAs and equity is only changing now, and not in line with their values.
OpenAI sent an internal memo to former employees, releasing them from controversial non-disparagement agreements that they had to sign in order to keep their vested company equity. The NDAs did not have an expiration date and effectively forced employees to choose between signing them or losing their equity. The new memo stated that OpenAI would not cancel any vested equity units regardless of whether employees signed the NDAs. OpenAI co-founders expressed regret that the language around NDAs and equity is only changing now, and not in line with their values.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_5k-arena-124-nbha-124-future-fortunes-124-barrel-race.webp "Yanasa TV")
_ozempic-and-wegovy-can-lead-to-major-muscle-loss-this-company-may-have-a-solution.webp "Dr. Jordan R. Plews, PhD, Co-Founder & CEO of Elevai Labs, Inc, was recently a guest on Benzinga's All Access.<br/><br/>Elevai is a medical aesthetic biotechnology company that develops innovative skincare products and treatments tied to obesity and metabolic health. The company's biotech division is currently developing EL-22, designed to help users of drugs like Ozempic keep lean muscle mass as they lose weight.<br/><br/>The company recently released preclinical data showing promising results for EL-22.")
_chad-amp-zip-5-3-14-hull-nbha.webp "cacleigh")
_harley-nbha-co-03-cactus-creek-8-9-15.webp "Kelsey Bault")
_slinky-nbha-co-03-cactus-creek-9-20-15-2.webp "Kelsey Bault")
_slinky-nbha-co-03-district-finals-10-11-2015.webp "Kelsey Bault")
_the-cast-of-39generation39-124-how-well-do-you-know-your-co-star-124-marie-claire.webp "Chloe East, Uly Schlesinger, Lukita Maxwell, Nathanya Alexander and Haley Sanchez of the HBO Max series \")
_harley-nbha-co-03-lazy-h-8-7-15.webp "Kelsey Bault")
_5k-arena-124-nbha-124-future-fortunes-124-barrel-race.jpg)
_ozempic-and-wegovy-can-lead-to-major-muscle-loss-this-company-may-have-a-solution.jpg)
_chad-amp-zip-5-3-14-hull-nbha.jpg)
_harley-nbha-co-03-cactus-creek-8-9-15.jpg)
_slinky-nbha-co-03-cactus-creek-9-20-15-2.jpg)
_slinky-nbha-co-03-district-finals-10-11-2015.jpg)
_the-cast-of-39generation39-124-how-well-do-you-know-your-co-star-124-marie-claire.jpg)
_harley-nbha-co-03-lazy-h-8-7-15.jpg)
![[+]](/images/menu.gif){kind=small}